E-Mail
IMAGE: Nirmal Verma, Ph.D., and several other researchers contributed to the recent study potentially linking low blood amylin levels to reduced progression of Alzheimer s disease. view more
Credit: Photo by Pete Comparoni | UKphoto
LEXINGTON, Ky. (January 20, 2021) - More than 5.7 million Americans live with Alzheimer s disease and that number is projected to triple by 2050. Despite the growing number there is not a cure. Florin Despa a professor with the University of Kentucky s department of pharmacology and nutritional sciences says, The mechanisms underlying neurodegenerative diseases are largely unknown and effective therapies are lacking. That is why numerous studies and trials are ongoing around the world including at the University of Kentucky. One of those studies by University of Kentucky researchers was recently published in